Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trial

scientific article

Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.THROMRES.2016.01.004
P698PubMed publication ID26916299

P50authorJohn W. EikelboomQ42846212
Salim YusufQ2214381
Lars WallentinQ6230815
Muredach P. ReillyQ51505621
Alex C SpyropoulosQ90710748
James DouketisQ100404477
Jonas OldgrenQ106086753
Michael D. EzekowitzQ110902282
Mandy FraessdorfQ114775432
P2093author name stringStuart J Connolly
Martina Brueckmann
Jeff S Healey
P921main subject(RS)-warfarinQ407431
dabigatranQ419345
P304page(s)77-81
P577publication date2016-01-09
P1433published inThrombosis ResearchQ15758741
P1476titleUrgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trial
P478volume139

Reverse relations

cites work (P2860)
Q47221597Association of Atrial Fibrillation and Oral Anticoagulant Use With Perioperative Outcomes After Major Noncardiac Surgery.
Q39129273Dabigatran Etexilate: A Review in Nonvalvular Atrial Fibrillation
Q48149529Dabigatran level monitoring prior to idarucizumab administration in patients requiring emergent cardiac surgery
Q47654635Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease.
Q51007969Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD™ study.
Q92624903Idarucizumab for a traumatic head injury patient taking dabigatran
Q50875752Managing direct oral anticoagulants in patients undergoing dentoalveolar surgery.
Q64928648Practical considerations on anticoagulation reversal: spotlight on the reversal of dabigatran.
Q37680793Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases.
Q48341889Reversal of dabigatran-associated bleeding using idarucizumab: review of the current evidence.
Q52603801Simultaneous Pancreas-Kidney Transplantation in a Patient with Heparin-Induced Thrombocytopenia on Dabigatran Therapy.
Q28066262Spotlight on idarucizumab and its potential for the reversal of anticoagulant effects of dabigatran
Q38829586The discovery of dabigatran etexilate for the treatment of venous thrombosis
Q48022060Update in perioperative medicine: practice changing evidence published in 2016.

Search more.